Power injection

August 2, 2008

Email this news item to a friend/colleague

Covidien, announced the U.S. commercial availability of Covidien Imaging Solutions’ contrast delivery system with radio-frequency identification (RFID) technology. The components integrate RFID technology to create a system that is designed to aid in patient safety by helping to reduce the risk of medical errors in radiology departments.

Covidien’s contrast delivery system combines its unit-dose RFID-enabled Ultraject(TM) prefilled contrast media syringes with its RFID-enabled Optivantage(TM) DH power injector to provide the only contrast delivery solution of its type available in North America. RFID is an automatic identification technology that captures, stores and transmits data between the RFID-enabled Ultraject prefilled syringe and the RFID-enabled Optivantage DH power injector using devices called RFID transponders, or tags.

“Covidien’s new, innovative system has the potential to help reduce medical errors and increase efficiency in CT imaging,” said Steve Hanley, President, Imaging Solutions, Covidien. “We expect this technology to be the platform for future innovation.”

Click here for the full story.